Springworks Therapeutics Stock Price History
SWTX Stock | USD 49.89 1.19 2.33% |
Below is the normalized historical share price chart for SpringWorks Therapeutics extending back to September 13, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of SpringWorks Therapeutics stands at 49.89, as last reported on the 23rd of March, with the highest price reaching 50.71 and the lowest price hitting 49.53 during the day.
If you're considering investing in SpringWorks Stock, it is important to understand the factors that can impact its price. SpringWorks Therapeutics appears to be very steady, given 3 months investment horizon. SpringWorks Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11 % return per unit of risk over the last 3 months. By inspecting SpringWorks Therapeutics' technical indicators, you can evaluate if the expected return of 0.64% is justified by implied risk. Please review SpringWorks Therapeutics' Risk Adjusted Performance of 0.0922, coefficient of variation of 1059.92, and Semi Deviation of 3.92 to confirm if our risk estimates are consistent with your expectations.
At this time, SpringWorks Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 114.6 M in 2025, whereas Treasury Stock is likely to drop (792.9 K) in 2025. . At this time, SpringWorks Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.34 in 2025, whereas Price To Sales Ratio is likely to drop 13.28 in 2025. SpringWorks Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of June 1987 | 200 Day MA 38.96 | 50 Day MA 46.527 | Beta 0.756 |
SpringWorks |
Sharpe Ratio = 0.1053
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | SWTX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
6.12 actual daily | 54 54% of assets are less volatile |
Expected Return
0.64 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average SpringWorks Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SpringWorks Therapeutics by adding it to a well-diversified portfolio.
Price Book 7.7739 | Enterprise Value Ebitda (7.90) | Price Sales 19.5134 | Shares Float 73.8 M | Wall Street Target Price 72.875 |
SpringWorks Therapeutics Stock Price History Chart
There are several ways to analyze SpringWorks Stock price data. The simplest method is using a basic SpringWorks candlestick price chart, which shows SpringWorks Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 20, 2025 | 59.93 |
Lowest Price | January 14, 2025 | 32.5 |
SpringWorks Therapeutics March 23, 2025 Stock Price Synopsis
Various analyses of SpringWorks Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell SpringWorks Stock. It can be used to describe the percentage change in the price of SpringWorks Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of SpringWorks Stock.SpringWorks Therapeutics Price Action Indicator | (0.82) | |
SpringWorks Therapeutics Price Daily Balance Of Power | (1.01) | |
SpringWorks Therapeutics Price Rate Of Daily Change | 0.98 |
SpringWorks Therapeutics March 23, 2025 Stock Price Analysis
SpringWorks Stock Price History Data
The price series of SpringWorks Therapeutics for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 27.43 with a coefficient of variation of 19.44. The price distribution for the period has arithmetic mean of 44.26. The median price for the last 90 days is 40.49.Open | High | Low | Close | Volume | ||
03/23/2025 | 50.71 | 50.71 | 49.53 | 49.89 | ||
03/21/2025 | 50.71 | 50.71 | 49.53 | 49.89 | 2,441,661 | |
03/20/2025 | 50.19 | 51.43 | 50.15 | 51.08 | 1,483,441 | |
03/19/2025 | 49.00 | 50.88 | 48.90 | 50.63 | 909,227 | |
03/18/2025 | 49.42 | 50.32 | 48.69 | 49.04 | 2,291,058 | |
03/17/2025 | 51.01 | 51.01 | 47.70 | 49.84 | 1,351,752 | |
03/14/2025 | 50.20 | 51.51 | 48.94 | 51.14 | 1,698,621 | |
03/13/2025 | 50.65 | 51.51 | 48.64 | 49.77 | 1,648,784 | |
03/12/2025 | 51.10 | 52.40 | 50.31 | 50.88 | 1,599,464 | |
03/11/2025 | 48.50 | 51.67 | 47.41 | 50.89 | 2,278,527 | |
03/10/2025 | 47.63 | 49.26 | 46.63 | 48.44 | 2,462,774 | |
03/07/2025 | 51.52 | 53.34 | 49.31 | 49.55 | 2,504,197 | |
03/06/2025 | 51.56 | 53.51 | 51.03 | 51.32 | 4,373,479 | |
03/05/2025 | 51.60 | 52.15 | 49.82 | 50.59 | 3,369,254 | |
03/04/2025 | 52.79 | 53.60 | 51.27 | 51.38 | 2,048,817 | |
03/03/2025 | 56.70 | 56.90 | 52.60 | 53.28 | 2,849,983 | |
02/28/2025 | 55.20 | 58.10 | 54.05 | 57.76 | 3,480,418 | |
02/27/2025 | 54.35 | 55.04 | 53.17 | 53.41 | 1,717,584 | |
02/26/2025 | 54.89 | 55.89 | 54.12 | 54.14 | 1,162,424 | |
02/25/2025 | 55.95 | 56.14 | 53.31 | 54.03 | 3,381,389 | |
02/24/2025 | 56.85 | 57.72 | 55.81 | 56.56 | 2,464,046 | |
02/21/2025 | 60.01 | 60.20 | 57.72 | 58.25 | 3,532,160 | |
02/20/2025 | 62.00 | 62.00 | 58.84 | 59.93 | 5,140,672 | |
02/19/2025 | 56.49 | 57.19 | 54.89 | 55.73 | 2,578,687 | |
02/18/2025 | 55.80 | 57.00 | 55.01 | 56.30 | 3,782,020 | |
02/14/2025 | 58.91 | 60.00 | 57.27 | 57.43 | 2,781,105 | |
02/13/2025 | 58.37 | 59.66 | 57.25 | 58.59 | 2,869,371 | |
02/12/2025 | 57.51 | 59.78 | 55.80 | 59.28 | 4,270,490 | |
02/11/2025 | 53.75 | 56.62 | 50.81 | 55.13 | 8,245,843 | |
02/10/2025 | 41.00 | 60.00 | 40.48 | 54.00 | 15,997,800 | |
02/07/2025 | 39.23 | 40.95 | 39.10 | 40.28 | 1,453,681 | |
02/06/2025 | 41.29 | 41.72 | 39.23 | 39.28 | 1,342,681 | |
02/05/2025 | 38.52 | 41.28 | 38.52 | 41.00 | 2,596,291 | |
02/04/2025 | 35.95 | 40.12 | 35.95 | 38.40 | 2,972,236 | |
02/03/2025 | 36.93 | 37.08 | 35.40 | 35.82 | 1,118,954 | |
01/31/2025 | 37.35 | 39.10 | 36.85 | 37.50 | 1,082,639 | |
01/30/2025 | 36.59 | 37.87 | 36.10 | 37.23 | 732,042 | |
01/29/2025 | 35.71 | 37.00 | 35.66 | 36.52 | 786,673 | |
01/28/2025 | 36.00 | 36.73 | 35.40 | 35.89 | 1,156,493 | |
01/27/2025 | 36.06 | 38.68 | 35.36 | 35.82 | 1,907,777 | |
01/24/2025 | 35.72 | 37.29 | 35.67 | 36.16 | 1,355,536 | |
01/23/2025 | 34.75 | 36.25 | 34.42 | 36.14 | 1,366,312 | |
01/22/2025 | 35.76 | 36.99 | 34.38 | 35.00 | 1,657,173 | |
01/21/2025 | 34.86 | 37.59 | 34.63 | 36.35 | 1,303,474 | |
01/17/2025 | 36.00 | 37.04 | 34.09 | 34.63 | 1,225,550 | |
01/16/2025 | 33.57 | 36.09 | 33.57 | 35.59 | 1,402,801 | |
01/15/2025 | 32.47 | 34.49 | 31.96 | 33.48 | 1,753,738 | |
01/14/2025 | 37.36 | 38.25 | 32.38 | 32.50 | 2,671,840 | |
01/13/2025 | 38.50 | 39.44 | 35.22 | 37.01 | 3,626,045 | |
01/10/2025 | 39.78 | 44.01 | 38.43 | 43.00 | 3,630,978 | |
01/08/2025 | 40.89 | 42.30 | 39.74 | 40.49 | 2,076,481 | |
01/07/2025 | 38.80 | 45.65 | 37.90 | 41.20 | 4,004,388 | |
01/06/2025 | 38.21 | 40.03 | 37.77 | 38.86 | 1,352,071 | |
01/03/2025 | 36.11 | 38.57 | 36.11 | 38.19 | 994,732 | |
01/02/2025 | 36.32 | 37.88 | 35.99 | 36.08 | 616,377 | |
12/31/2024 | 36.43 | 36.90 | 35.91 | 36.13 | 578,084 | |
12/30/2024 | 35.95 | 36.93 | 35.39 | 36.34 | 754,929 | |
12/27/2024 | 36.82 | 37.40 | 35.73 | 36.35 | 602,665 | |
12/26/2024 | 36.56 | 37.38 | 36.20 | 37.14 | 481,534 | |
12/24/2024 | 37.33 | 37.60 | 36.59 | 36.81 | 286,225 | |
12/23/2024 | 35.47 | 37.80 | 35.12 | 37.37 | 687,763 |
About SpringWorks Therapeutics Stock history
SpringWorks Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for SpringWorks is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in SpringWorks Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing SpringWorks Therapeutics stock prices may prove useful in developing a viable investing in SpringWorks Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 74.1 M | 53.5 M | |
Net Loss | -249.7 M | -237.2 M |
SpringWorks Therapeutics Quarterly Net Working Capital |
|
SpringWorks Therapeutics Stock Technical Analysis
SpringWorks Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
SpringWorks Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for SpringWorks Therapeutics' price direction in advance. Along with the technical and fundamental analysis of SpringWorks Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of SpringWorks to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0922 | |||
Jensen Alpha | 0.5959 | |||
Total Risk Alpha | 1.01 | |||
Sortino Ratio | 0.147 | |||
Treynor Ratio | 0.8682 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for SpringWorks Stock Analysis
When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.